FST,which is more specific to depression-related pharmacology research,also had similar results.29 Beneficialeffects on depressive-like symptoms were observed in the n-3 PUFA-treatedgroup (FAS group), while no such effects were seen in the n-6 PUFA-treatedgroup (CAS). The gene discussed is FAS; the disease is major depressive disorder.